BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scioli Montoto S, Muraca G, Di Ianni M, Couyoupetrou M, Pesce G, Islan G, Chain C, Vela M, Ruiz M, Talevi A, Castro G. Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices. Journal of Drug Delivery Science and Technology 2021;63:102470. [DOI: 10.1016/j.jddst.2021.102470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Scioli-montoto S, Sbaraglini ML, Cisneros JS, Chain CY, Ferretti V, León IE, Alvarez VA, Castro GR, Islan GA, Talevi A, Ruiz ME. Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation. Front Chem 2022;10:908386. [DOI: 10.3389/fchem.2022.908386] [Reference Citation Analysis]
2 Medina-montano C, Rivero Berti I, Gambaro RC, Limeres MJ, Svensson M, Padula G, Chain CY, Cisneros JS, Castro GR, Grabbe S, Bros M, Gehring S, Islan GA, Cacicedo ML. Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells. Pharmaceutics 2022;14:1611. [DOI: 10.3390/pharmaceutics14081611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bonilla L, Esteruelas G, Ettcheto M, Espina M, García ML, Camins A, Souto EB, Cano A, Sánchez-López E. Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges. Epilepsia Open 2021. [PMID: 34862851 DOI: 10.1002/epi4.12567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]